Entities / Company
Sanofi (Japan).
company in Tokyo, Japan
- Reports this week
- 0
- Active events
- 0
- Connections
- 22
What's happening
Gone quiet
No new reports in 90+ days-
Alnylam is headquartered in Cambridge, MA, and engages with users on X (formerly Twitter), LinkedIn, and Instagram. Novartis and Sanofi are partners in commercializing Alnylam products.Some support2 reports
-
Major pharmaceutical companies are heavily investing in R&D for multiple myeloma treatments across Europe.Some support1 report1 development inside
-
Sanofi announced the sale of INBRX-101 from Inhibrx Biosciences via a license and assignment agreement on August 14, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Sanofi (Japan) this week
News at the entities that move Sanofi (Japan) most-
Regeneron Pharmaceuticals Mentioned togetherRegeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Moves Sanofi (Japan)
Connections
The 1 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Regeneron Pharmaceuticals Mentioned together
Both companies are noted for operating in the pharmaceutical sector and reporting results from late-stage studies.
History
Events by the month they beganJune 2026
3 events- Alnylam is headquartered in Cambridge, MA, and engages with users on X (formerly Twitter), LinkedIn, and Instagram. Novartis and Sanofi are partners in commercializing Alnylam products.
- Major pharmaceutical companies are heavily investing in R&D for multiple myeloma treatments across Europe.
- Sanofi announced the sale of INBRX-101 from Inhibrx Biosciences via a license and assignment agreement on August 14, 2025.